As of January 22, 2025, Omeros Corporation (OMER) has a market cap of $0.54 billion USD. According to our data, Omeros Corporation is ranked No.6024 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.54 B |
-5.97%
|
Dec 31, 2024 | $0.57 B |
202.14%
|
Dec 29, 2023 | $0.19 B |
44.69%
|
Dec 30, 2022 | $0.13 B |
-64.85%
|
Dec 31, 2021 | $0.37 B |
-55.00%
|
Dec 31, 2020 | $0.83 B |
1.42%
|
Dec 31, 2019 | $0.82 B |
26.48%
|
Dec 31, 2018 | $0.65 B |
-42.67%
|
Dec 29, 2017 | $1.13 B |
95.87%
|
Dec 30, 2016 | $0.57 B |
-36.94%
|
Dec 31, 2015 | $0.91 B |
-36.52%
|
Dec 31, 2014 | $1.44 B |
119.49%
|
Dec 31, 2013 | $0.65 B |
117.53%
|
Dec 31, 2012 | $0.30 B |
31.39%
|
Dec 30, 2011 | $0.23 B |
-52.06%
|
Dec 31, 2010 | $0.48 B |
17.38%
|
Dec 31, 2009 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Market Cap | = | OMER Stock Price | * | OMER Shares Outstanding |
= | $9.29 | * | 57.95 M | |
= | $0.54 B |